InvestorsHub Logo
Followers 11
Posts 1455
Boards Moderated 0
Alias Born 02/01/2013

Re: stocky101 post# 850

Friday, 09/29/2017 8:33:17 AM

Friday, September 29, 2017 8:33:17 AM

Post# of 2676
Analyst Actions: Piper Jaffray Upgrades Zynerba Pharmaceuticals to Overweight from Neutral
BY MT Newswires
— 7:08 AM ET 09/29/2017
07:08 AM EDT, 09/29/2017 (MT Newswires) -- Zynerba Pharmaceuticals' ( ZYNE ) average rating among analysts is a hold, with an average price target of $11.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News